-
Mashup Score: 2Optimizing nAMD and DME Treatment: Real-World Durability, and Fluid Outcomes with Second Generation Anti-VEGF Agents - 4 day(s) ago
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
Source: www.hcplive.comCategories: General Medicine NewsTweet
Achieving long-term control in nAMD & DME means looking beyond efficacy. Explore durability, fluid outcomes & real-world strategies in this expert Medcast. Listen now: https://t.co/YHeAbvh2UP #Retina #nAMD #DME #Ophthalmology #AntiVEGF https://t.co/ndQd08cQeR